구조 생물학 및 분자 모델링 기술 시장 : 도구별, 용도별 - 세계 예측(2025-2030년)

The Structural Biology & Molecular Modeling Techniques Market was valued at USD 9.39 billion in 2023, expected to reach USD 11.10 billion in 2024, and is projected to grow at a CAGR of 18.34%, to USD 30.52 billion by 2030.

Structural biology and molecular modeling are pivotal to understanding biological processes at an atomic level, offering vital insights for drug discovery and development, genetic research, and biotechnology. The scope encompasses the use of advanced techniques such as X-ray crystallography, NMR spectroscopy, and cryo-electron microscopy for visualizing macromolecular structures, complemented by computational methods like molecular dynamics simulations and homology modeling to predict molecular behavior and interactions. These techniques are crucial for pharmaceutical companies in drug design and lead optimization, academic institutions for comprehensive biological research, and biotech firms for developing novel therapeutic strategies.

The market for structural biology and molecular modeling is primarily driven by the increasing demand for targeted therapies and personalized medicine, the complexity of diseases necessitating advanced research approaches, and technological advancements in imaging and computational techniques. Potential opportunities lie in the integration of AI and machine learning for predictive modeling, expansion of cloud-based tools for enhanced data sharing and collaboration, and the growth of biologics and biosimilars demanding detailed structural analysis. However, challenges like high costs of equipment, the complexity of data interpretation, and the need for highly skilled personnel can restrict market growth.

Innovation opportunities are abundant in developing cost-effective technologies, automating data processing and analysis pipelines, and expanding applications in non-pharmaceutical sectors such as agricultural biotechnology and environmental sciences. The market is characterized by rapid advancements requiring continuous adaptation and investment in R&D to maintain competitiveness. Recommendations for businesses include prioritizing strategic partnerships, focusing on training programs to bridge the skill gap, and investing in scalable technologies that can cater to evolving scientific needs. Despite the barriers, the expanding scope of molecular modeling in innovative therapeutic design and its indispensability in modern research laboratories present substantial prospects for growth and development.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Structural Biology & Molecular Modeling Techniques Market

The Structural Biology & Molecular Modeling Techniques Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing incidences of chronic diseases coupled with acquired drug resistance property
  • Increasing demand attributed to high drug attrition rate and late-phase clinical trials in drug development
  • Reduced probability of drug failure with use of prediction software
• Market Restraints
  • Relatively high cost of the equipment and lack of sufficient facilities in underdeveloped countries
• Market Opportunities
  • Emerging technological innovations with the development of validated mathematical models for identification of novel leads
  • Increasing developments in optimization of drug discovery process with biomedical research
• Market Challenges
  • Dearth of skilled professional

Porter's Five Forces: A Strategic Tool for Navigating the Structural Biology & Molecular Modeling Techniques Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Structural Biology & Molecular Modeling Techniques Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Structural Biology & Molecular Modeling Techniques Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Structural Biology & Molecular Modeling Techniques Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Structural Biology & Molecular Modeling Techniques Market

A detailed market share analysis in the Structural Biology & Molecular Modeling Techniques Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Structural Biology & Molecular Modeling Techniques Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Structural Biology & Molecular Modeling Techniques Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Structural Biology & Molecular Modeling Techniques Market

A strategic analysis of the Structural Biology & Molecular Modeling Techniques Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Structural Biology & Molecular Modeling Techniques Market, highlighting leading vendors and their innovative profiles. These include Acellera Ltd., Agilent Technologies, Inc., Biomax Informatics AG, Bruker Corporation, Chemical Computing Group ULC, Dassault Systemes, Illumina, Inc., and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Structural Biology & Molecular Modeling Techniques Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Tools, market is studied across Databases, SaaS & Standalone Modeling, and Visualization & Analysis. The SaaS & Standalone Modeling is further studied across Antibodies, Homology Modeling, Hybrid, Molecular Dynamics, and Threading.
• Based on Application, market is studied across Drug Development and Drug Discovery.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing incidences of chronic diseases coupled with acquired drug resistance property
    • 5.1.1.2. Increasing demand attributed to high drug attrition rate and late-phase clinical trials in drug development
    • 5.1.1.3. Reduced probability of drug failure with use of prediction software
  • 5.1.2. Restraints
    • 5.1.2.1. Relatively high cost of the equipment and lack of sufficient facilities in underdeveloped countries
  • 5.1.3. Opportunities
    • 5.1.3.1. Emerging technological innovations with the development of validated mathematical models for identification of novel leads
    • 5.1.3.2. Increasing developments in optimization of drug discovery process with biomedical research
  • 5.1.4. Challenges
    • 5.1.4.1. Dearth of skilled professional
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Structural Biology & Molecular Modeling Techniques Market, by Tools

• 6.1. Introduction
• 6.2. Databases
• 6.3. SaaS & Standalone Modeling
  • 6.3.1. Antibodies
  • 6.3.2. Homology Modeling
  • 6.3.3. Hybrid
  • 6.3.4. Molecular Dynamics
  • 6.3.5. Threading
• 6.4. Visualization & Analysis

7. Structural Biology & Molecular Modeling Techniques Market, by Application

• 7.1. Introduction
• 7.2. Drug Development
• 7.3. Drug Discovery

8. Americas Structural Biology & Molecular Modeling Techniques Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Structural Biology & Molecular Modeling Techniques Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Structural Biology & Molecular Modeling Techniques Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Acellera Ltd.
• 2. Agilent Technologies, Inc.
• 3. Biomax Informatics AG
• 4. Bruker Corporation
• 5. Chemical Computing Group ULC
• 6. Dassault Systemes
• 7. Illumina, Inc.
• 8. Thermo Fisher Scientific Inc.